Can a GLP-1 Shrink Your Menopause Belly? What New Science Tells Us
GLP-1 receptor agonists, like semaglutide and tirzepatide, are making headlines not just for dramatic weight loss, but also by proving to help target this hormone-driven transformation.
More from Flow Space
Menopause and Mental Health: Coping with Mood Swings and Anxiety
But can these drugs really help shrink the hormonal belly bulge? What does the latest science say about GLP-1 safety and effectiveness for midlife women? Here's what you need to know.
Menopause belly refers to the increase in abdominal fat that many women experience during and after menopause.
'This shift is driven primarily by hormonal changes, specifically the decrease in estrogen,' Catherine Metzgar, PhD, RD, director of coaching operations at Virta Health, told Flow Space. 'Estrogen plays a key role in regulating body fat distribution, and when levels decline, fat tends to accumulate more viscerally which is around abdominal organs.'
This is a shift from pre-menopause, when fat tends to accumulate more in the hips and thighs.
Other factors that contribute include:
Insulin resistance or insulin sensitivity—associated with increased fat accumulation.
Muscle loss—decreases with age, less muscles results in a slow metabolism.
Stress and sleep issues—increase cortisol levels, which are linked to abdominal fat storage.
These metabolic shifts do have long-term impacts on our health, added Metzgar. Visceral fat is linked to an increased risk for metabolic syndrome, type 2 diabetes and heart disease.
Originally developed for type 2 diabetes, GLP-1 drugs mimic a gut hormone that regulates blood sugar, curbs appetite and slows digestion. This can result in a reduced appetite, improved insulin sensitivity and weight loss, specifically in visceral fat. These effects are especially relevant during menopause, when insulin resistance tends to rise and metabolism slows.
'These GLP-1 medications can help by slowing the time it takes for your stomach to empty and by making you feel fuller longer,' Dr. Brunilda Nazario, chief medical officer at WebMD told Flow Space. 'These drugs can help restore your metabolism, making it easier to lose weight and improve body shape.'
And now a new study has found that GLP-1 agonist, tirzepatide, can help with overall weight loss, as well as reduce deep abdominal fat and improve key cardiometabolic markers.
Physicians from New York-Presbyterian and Weill Cornell Medicine found that a primary concern for women in menopause is weight gain. In order to better understand GLP-1s efficacy for women in midlife, they conducted a secondary analysis of data from the SURMOUNT clinical trial to determine the efficacy of tirzepatide in women in the premenopausal, perimenopausal and postmenopausal stages of life.
What they found was that regardless of reproductive stage, tirzepatide was associated with significant body weight, waist circumference and waist-to-height ratio reductions in women living with obesity or who are overweight.
Tirzepatide, like other GLP-1s, delay gastric emptying and increase feelings of fullness, which help to reduce appetite and, therefore, food intake. These medications also improve insulin response and glucose control, which also supports weight loss.
'These results are not surprising and are consistent with other research evaluating GLP-1 medications and observed weight loss,' says Metzgar. 'Therefore, the findings can likely be applied to other GLP-1 agonists beyond tirzepatide. Even the authors of the study make a similar conclusion.'
The researchers found that tirzepatide worked by targeting the visceral fat in menopausal women in the same way it targets fat for other individuals who used GLP-1 drugs. They also noted that lifestyle changes, like proper diet and exercise, were also an important piece of the equation to ensure optimal results.
'Based on our research, we believe clinicians prescribing tirzepatide can feel more confident recommending the medication to their patients, especially women reporting menopause-related weight gain,' the researchers concluded. 'The data provides reassurance that this medication is effective in the setting of perimenopause and menopause.'
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Buzz Feed
2 days ago
- Buzz Feed
People Share Frustrating Parts Of Today's Beauty Standards
As women in the modern world, it's hard enough dealing with everyday pressures. But on top of that, there's the added stress of having to look a certain way — especially with social media broadcasting idealized versions of faces and bodies. Are people allowed to have fine lines and wrinkles anymore? Be in public without a stitch of makeup? Do we all need to have a perfectly slim waist, but curves in all the other right places? Have rock-hard abs and less than 20% body fat? It's a cycle of trying to find peace, then logging into social media and seeing everyone looking perfect. Ladies, it's time to share your opinon: What are the most frustrating parts of today's beauty standards? Is it the pressure to get Botox and fillers? To fall into a certain weight range with medications like GLP-1s on the rise? Will you share your frustrations with us? Share your thoughts in the comments. For those who prefer to stay anonymous, you can fill out the anonymous form below. Your response may be featured in an upcoming BuzzFeed post.
Business Wire
2 days ago
- Business Wire
MedCity News Report Reveals Employers are Turning to AI-Powered, Clinically Integrated Independent Healthcare Navigation to Combat Rising Costs
DUBLIN, Ohio--(BUSINESS WIRE)--As employers face mounting pressure to improve health outcomes while managing rising costs, a new report sponsored by Quantum Health reveals a significant shift in how benefit consultants are advising self-insured employers to build and evaluate healthcare benefit strategies. The 2025 Benefits Sentiment Index, conducted in partnership with MedCity News, offers a data driven look into the top challenges and emerging priorities shaping the benefits landscape. "Independent navigation is accelerating as a central benefits strategy, not only to improve the member experience, but to lower costs, improve value on investment and seamlessly integrate AI-driven innovations with compassionate, human-centered care." Share Now in its third year, the Index surveyed more than 120 experienced benefit consultants and uncovered a growing demand for independent, clinically integrated navigation models and a rising dissatisfaction with traditional carrier-provided services. Among the key findings: 68% of surveyed consultants guide clients away from navigation solutions tied to insurance carriers, instead recommending independent partners citing the need for a stronger member experience, clinical integration and transparency in cost savings. 87% of surveyed consultants report advising on GLP-1 drug coverage, with most recommending restrictions and measurable outcomes to ensure cost-effectiveness. The influence of AI continues to grow, with 72% of consultants surveyed counseling clients on its use in benefits — up significantly from the prior year. 'We're excited to once again collaborate with MedCity News on the Benefits Sentiment Index, bringing forward the key priorities shaping the healthcare benefits landscape,' said Dayne Williams, CEO of Quantum Health. 'This year's findings highlight how independent healthcare navigation is accelerating as a central healthcare benefits strategy — not only to simplify and improve the member healthcare experience, but also to lower costs, improve value on investment and seamlessly integrate AI-driven innovations with compassionate, human-centered care.' Williams added, "As the only navigation solution that engages continuously with providers from the member's first moment of need, we take immediate action to guide care decisions in real time. Leveraging advanced AI and our proprietary Real-Time Intercept® platform, we proactively identify members at critical moments and connect them to the right care at the right time. This approach combines clinical expertise with accelerated intervention — delivering independently validated results, improved health outcomes and a better experience for members.' The report also calls attention to gaps in engagement and personalization, with half of consultants reporting that their clients struggle with fragmented care coordination, lack of centralized access and difficulty engaging employees. Consultants are increasingly seeking solutions that integrate clinical care teams, embed AI for proactive risk detection, and provide seamless connections to behavioral health and social determinants of health support. 'At MedCity News, we're committed to surfacing insights that drive smarter healthcare decisions, and this year's Index does exactly that,' said Ken Montgomery, publisher of MedCity News. 'The data reveals a clear call to action: self-insured employers and their consultants are demanding more from navigation solutions — more clinical integration, more actionable data and more alignment with evolving technologies like AI. We're proud to partner with Quantum Health to spotlight these critical shifts and help advance the conversation on what effective benefits strategy looks like today.' 'The takeaway is clear,' said Williams. 'Employers are no longer satisfied with the status quo. The next chapter of healthcare navigation must be clinically integrated, AI-enabled and relentlessly focused on driving measurable results.' The full 2025 Benefits Sentiment Index is available for download here. About MedCity News MedCity News is the go-to digital destination for B2B healthcare innovation news, informing decision-makers of trends in the healthcare industry. MedCity News produces dynamic and unique innovation-focused events for the entire healthcare ecosystem, gathering experts from across disciplines to address the challenges facing the industry. MedCity News also produces the Debunked videocast, as well as several podcasts: MedCity Pivot, MedCity Moves and MedCity FemFwd. MedCity News is owned by Breaking Media, a network of websites, e-newsletters, events and social media channels for influential, affluent business communities. To learn more visit MedCity News. About Quantum Health Celebrating 25 years of innovation, Quantum Health is a leading consumer healthcare navigation and care coordination company. Its Real-Time Intercept® platform identifies early intervention opportunities to improve engagement, outcomes, and cost efficiency. Based in Dublin, Ohio, Quantum Health has earned national recognition for growth and workplace culture, including honors from FORTUNE, Inc. 5000, and the Women Presidents' Organization. To learn more, visit and connect on LinkedIn.
Newsweek
2 days ago
- Newsweek
How Health Insurance Rates Could Rise in Florida in 2026
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. Hundreds of thousands of Florida residents could see their health insurance premiums soar by double-digit increases. Fourteen major insurers, including Molina Healthcare, AmeriHealth Caritas, Centene Venture Company and Blue Cross and Blue Shield of Florida, have proposed to increase the premiums for those on Affordable Care Act (ACA)-compliant plans in 2026. Florida is not the only state where such increases are happening, as these health insurance premium increases are "fairly routine," Kosali Simon, a health economist and associate vice provost for Health Sciences at Indiana University Bloomington, told Newsweek. Simon said that while companies proposing premium increases is not new, the "size of the increases insurers are asking for 2026 is larger than usual." Last year, the median proposed increase was 7 percent, and for 2026 that number is currently 18 percent, KFF data shows, with some states, like Florida, seeing "especially high" increases, she said. A spokesperson for Florida Blue told Newsweek it "shares the concerns rising health insurance rates may cause for our members, communities, and other stakeholders." "The premium increases, which are an industry-wide issue, are a necessary response to federal regulatory changes, including the scheduled expiration of premium tax credits at the end of 2025, as well as the rising cost and utilization of medical care and prescription drugs," they added. Newsweek reached out to Molina Healthcare, AmeriHealth Caritas, and Centene Venture Company via email for comment. Why It Matters The rise in health insurance premiums is being broadly driven by a number of factors, including the increased cost and use of health care services. Inflation also plays a role, as well as the cost of health care, labor and increasing demand for medications like GLP-1 drugs like Ozempic and Wegovy, which ramp up prescription drug spending. However, while the increases are not new—insurers have been pushing up the costs of premiums for years—2026 is set to have the largest jump in cost since 2018, KFF data shows. The larger increase in 2026 is due to the fact that next year, enhanced tax credits are set to expire as President Donald Trump has not chosen to renew them. This means that out-of-pocket premium costs for ACA marketplace enrollees will increase by more than 75 percent, meaning many healthier enrollees could drop their coverage, which can, in turn, increase the cost of premiums. File photo: the exterior of the AdventHealth Clermont ER hospital in Clermont, Florida. File photo: the exterior of the AdventHealth Clermont ER hospital in Clermont, Florida. Phelan M. Ebenhack/AP What To Know Former President Joe Biden brought in temporary subsidies for those using ACA marketplaces and extended them to the end of 2025, helping more people have access to health care coverage. As the Trump administration has made no move to renew these subsidies, likely because they come at a steep cost to the taxpayer, they are currently set to expire at the end of the year, meaning premium costs for those using ACA marketplaces will soar. While there is still time for the administration to opt to extend the subsidies, "insurers may not want to take that gamble, and are increasing rates now," Simon said. This is because insurers are likely anticipating who will be buying health insurance. "The young and healthy may not be as likely to buy, and they help keep the costs for the insurers down, so this 'adverse selection' in insurance markets might be what's behind the premium increase," Simon said. In Florida, Molina Healthcare has said it wants to increase rates by just over 40 percent in 2026, which was more than any other plan. This would affect more than 90,000 policyholders. Meanwhile, AmeriHealth Caritas has proposed the second-highest premium increases, at an average price hike of 35 percent, impacting 55,000 policyholders Impacting more than 1.3 million Americans, Centene Venture Company has requested an increase of just over 18 percent. Florida Blue has also proposed to increase premium costs by nearly 27 percent, with some members seeing smaller increases, according to the local news outlet Creative Loafing Tampa Bay. Therefore, while these increases are happening across the country, compared to other states, "Florida seems particularly hard hit," Simon said. What People Are Saying A spokesperson for Florida Blue told Newsweek: "To support our members, we are educating them about the changes and providing personalized support – to help them navigate the enrollment process, understand their coverage options, determine if they qualify for financial assistance, and assist them with staying covered. We are dedicated to making high-quality health care more affordable and accessible to everyone." Mark Pauly, a professor of health care management at Wharton School of the University of Pennsylvania, told Newsweek: "The official government projections are for higher growth in medical spending nationwide, which translates into higher premiums, especially for exchange plans which are not allowed to have a large profit cushion. This high increase is a marked shift in a trend of health spending growth at the same rate as GDP—the share of health spending was the same in 2023 as in 2009." Pauly added: "The trends we are seeing of high claims growth are nationwide. There will be some variation across states but the trend will be common to all." Kosali Simon, a health economist and associate vice provost for Health Sciences at Indiana University Bloomington, told Newsweek: "For the majority of enrollees, especially those with federal premium tax credits, these price increases won't mean they have to pay more, as government subsidies adjust with benchmark plan prices." She added, "For those who don't qualify for subsidies, like many small business owners who buy through the exchange but have higher incomes, it's a problem. Those who have to pay more may drop coverage and become uninsured or have to cut back on other spending." What Happens Next The proposed increases are for the 2026 calendar year, and many are concerned about the impacts they will have on Americans. Pauly said higher premiums "will drive the middle income buyers of exchange insurance to take a chance and go uninsured or switch to a job that has health benefits."
